SWOT Analysis for IOL Chemicals and Pharmaceuticals Ltd.

Add SWOT widget to your site/app

Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Stocks whose current price is 20% higher than week low, and more than previous close
Stringent DVM Screener - maximize returns
Weekly Strategy: High Momentum Score Stocks (subscription)
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
New 52 week high today
Dividend yield greater than sector dividend yield
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing profits every quarter for the past 3 quarters
Increasing Revenue every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
RSI indicating price strength
High Volume, High Gain
Biggest Price Gainers from Open
Top Gainers
High Volume, High Gain
New 52 Week High
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Stocks whose current price is 20% higher than week low, and more than previous close

Stringent DVM Screener - maximize returns

Weekly Strategy: High Momentum Score Stocks (subscription)

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

New 52 week high today

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing profits every quarter for the past 3 quarters

Increasing Revenue every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

RSI indicating price strength

High Volume, High Gain

Biggest Price Gainers from Open

Top Gainers

High Volume, High Gain

New 52 Week High

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Annual net profit declining for last 2 years
Increasing Trend in Non-Core Income
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Annual net profit declining for last 2 years

Increasing Trend in Non-Core Income

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
Weekly Momentum Gainers
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

Weekly Momentum Gainers

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Trendlynes high return technically strong value stocks (subscription)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Decline in Quarterly Net Profit with falling Profit Margin (YoY)

Trendlynes high return technically strong value stocks (subscription)

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Decline in Quarterly Net Profit with falling Profit Margin (YoY)

IOL Chemicals and Pharmaceuticals Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

IOL Chemicals and Pharmaceuticals Ltd. has 34 Strengths, 6 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential